• AAPL 169.02
  • TSLA 162.13
  • AMZN 176.59
  • MSFT 409.06
  • INTC 34.5
  • EURUSD 1.0695
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. ST /
  3. AROC.ST

AroCell AB (AROC ST) stock market data APIs

kr0.394 0.03(8.2%) as of April 24, 2024

AroCell AB Financial Data Overview

0.175
0.394
-
-0.048
0.36
0.301-0.698
87 307 K
230 M
43 039 K
-0.0744
1.105
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'AROC',
Type: 'Common Stock',
Name: 'AroCell AB',
Exchange: 'ST',
CurrencyCode: 'SEK',
CurrencyName: 'Swedish krone',
CurrencySymbol: 'kr',
CountryName: 'Sweden',
CountryISO: 'SE',
ISIN: 'SE0003883990',
CIK: NULL,
EmployerIdNumber: '',
FiscalYearEnd: 'December',
IPODate: NULL,
InternationalDomestic: 'International',
Sector: 'Healthcare',
Industry: 'Diagnostics & Research',
}

AroCell AB Fundamental Data is available in our Financial Data APIs

  • Net Revenue 43 039 K
  • EBITDA -14 460 000
  • Earnings Per Share -0.26
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get AroCell AB Earnings via APIs

  • Latest Release 2024-02-22
  • EPS/Forecast NaN

Get AroCell AB End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get AroCell AB latest news via APIs

Thymidine Kinase 1 can be used for early detection of therapy response in breast cancer treatment

Patients treated with Epirubicin and Docetaxel before surgery were followed by their thymidine kinase (TK1) levels in blood to directly observe treatment response. The results show that a TK1-based ce...
  • AROCCELL
  • AROCELL
  • AROCELL AB
  • BIOMARKER
  • BIOMARKöR
  • BREAST CANCER
  • BRöSTCANCER
  • CANCER
  • CEO AROCELL
  • DIAGNOSTIC VALUE
  • KAROLINSKA INSTITUTE
  • KAROLINSKA INSTITUTET
  • ONCOLOGY
  • ONKOLOGI
  • SOLID TUMORS
  • STOCKHOLM STOCK EXCHANGE:AROC
  • THYMIDINE KINASE 1
  • TK 210 ELISA
  • TK1
  • VD AROCELL

AroCell expands with a Regulatory Affairs Director

AroCell AB (publ.) announces today that Peter Löwendahl joins the management team as senior director regulatory affairs. Peter Löwendahl will lead and develop AroCell’s regulatory strategy with fo...
  • AROCELL
  • AROCELL AB
  • BIOMARKER
  • BREAST CANCER
  • BRöSTCANCER
  • CEO AROCELL
  • FDA
  • MANGEMENT TEAM
  • MONOCLONAL ANTIBODIES
  • ONCOLOGY
  • PROSTATACANCER
  • PROSTATE CANCER
  • REGULATORY AFFAIRS
  • STOCKHOLM STOCK EXCHANGE:AROC
  • THYMIDINE KINASE
  • THYMIDINE KINASE 1
  • TK 210 ELISA
  • TK1
  • USA
  • VD AROCELL
Do you have any questions?
support@eodhistoricaldata.com